Related Experiment Video
Updated: Jul 9, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Erectile dysfunction medication use among men seeking substance abuse treatment
Keith J Horvath1, Donald A Calsyn, Christeine Terry
1Department of Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA. horva018@umn.edu
Many men in substance abuse treatment use erectile dysfunction (ED) medications, often obtained from physicians, to enhance sexual experiences rather than treat ED. This highlights potential health implications for heterosexual drug users.
Area of Science:
- Urology
- Addiction Medicine
- Sexual Health
Background:
- Limited research exists on erectile dysfunction (ED) medication use in heterosexual men with substance use disorders.
- Understanding ED medication acquisition and usage patterns is crucial for this population.
Purpose of the Study:
- To investigate the prevalence of ED medication use among men undergoing substance abuse treatment.
- To identify how these medications are obtained and their perceived sexual effects.
- To explore the association between ED medication use and stimulant use.
Main Methods:
- A cross-sectional, anonymous survey was administered to 297 men over 18 seeking outpatient substance abuse treatment.
- Data collected included demographics, primary substances of abuse, ED medication use history, acquisition methods, and reasons for use.
- Statistical analysis included calculating prevalence and odds ratios for associations.
Main Results:
- 24% of participants reported lifetime use of ED medications.
- Nearly 69% of ED medication users obtained them from a physician.
- 59% used ED medications for sexual enhancement, with a marginal association with stimulant use (OR = 3.86, p = .057).
Conclusions:
- ED medication use is prevalent among heterosexual men in substance abuse treatment.
- Physician acquisition is common, and non-therapeutic use for sexual enhancement is significant.
- These findings underscore the need to address the health implications of ED medication use in this population.
Related Concept Videos
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Drug Dependence
Drug Abuse and Addiction: Pharmacological Phenomena